sulfametrole

07/01/1986 - "Thus a single dose of trimethoprim-sulfametrole appears to be an effective treatment regimen for women with chancroid in Kenya."
07/14/1983 - "We conducted a randomized double-blind trial comparing a single dose of trimethoprim-sulfametrole (640 to 3200 mg) with five-day regimens of either trimethoprim-sulfametrole (160 to 800 mg twice daily) or trimethoprim alone (200 mg twice daily) for the treatment of men with chancroid. "
07/01/1986 - "Single-dose therapy with trimethoprim-sulfametrole for chancroid in females."
12/29/1983 - "Therapy of chancroid with trimethoprim-sulfametrole."
07/14/1983 - "We conclude that single-dose trimethoprim-sulfametrole is a highly effective, inexpensive therapy for chancroid in men and may prove to be an important strategy for the control of H. "

09/01/2011 - "Sulfametrole (SMT) combined with TMP could provide a choice for difficult-to-treat infections, particularly when administered intravenously. "
01/01/1981 - "The relationship of these results to the good clinical activity of the combination sulfametrole/trimethoprim in the treatment of infections of bacterial origin in the upper and lower airways is discussed."
02/29/1980 - "Because of the tendency of this metabolite to cumulation, in dialysis patients the compound preparation of trimethoprim and sulfametrol should be used only for trasient treatment of acute infections."
01/01/1975 - "Thirtyeight patients with a chronic urinary infection (definitions see methods) were treated for 3 months with Trimethoprim-Sulfametrol. "
09/05/1975 - "[Experience with a combination of sulfametrol and trimethoprim (Lidaprim) in otorhinilaryngologic infections]."

01/01/1975 - "[Sulfametrol-trimethoprim in the treatment of chronic urinary tract infections]."
05/21/1976 - "[Clinical testing of a combination of sulfametrol and trimethoprim (Lidaprim) in urinary tract infections of children]."
05/28/1981 - "Lidaprim, a bactericidal chemotherapeutical substance (combination of sulfametrol and trimethoprim), was administered to 29 patients with transverse lesions of the cord with paraplegia and urinary tract infections. "

07/01/1986 - "Women with genital ulcer disease who were culture-positive for Haemophilus ducreyi were treated with a single dose of the drug combination trimethoprim-sulfametrole; the dosage was 640 mg of trimethoprim and 3,200 mg of sulfametrole. "
01/01/1983 - "The TMP-SMZ and TMP-sulfametrole regimens were more effective than sulfadimidine, tetracycline, or single-dose doxycycline in curing ulcers. "
01/01/1983 - "One hundred fifty-one men with genital ulcer disease were assigned randomly to treatment with one of five oral antimicrobial regimens: (1) sulfadimidine (1 g four times daily for seven days); (2) tetracycline (500 mg four times daily for seven days); (3) trimethoprim-sulfamethoxazole (TMP-SMZ; 160 mg of TMP and 800 mg of SMZ twice daily for seven days); (4) doxycycline (300 mg as a single dose); or (5) TMP-sulfametrole (640 mg of TMP and 3,200 mg of sulfametrole once as a single dose). "

01/01/2020 - "Pharmacokinetics of trimethoprim/sulfametrole in critically ill patients on continuous renal replacement therapy."